Abstract: The invention relates to novel methods for making transparent and curved stromal cell tissues and decellularized forms thereof. Novel tissues are also provided.

Abstract: The present invention provides a method for increasing collagen production in a cell and a method for inhibiting cell migration. Further, the present invention provides a pharmaceutical composition comprising lipopeptides, wherein the lipopeptides substantially consist of ETTES lipopeptides, and uses of said pharmaceutical composition. The invention also provides a supramolecular structure comprising lipopeptides, wherein the lipopeptides substantially consist of ETTES lipopeptides, as well as a method for producing said supramolecular structure. The supramolecular structure of the invention may be used in the method for increasing collagen production and/or method for inhibiting cell migration.

Abstract: The present invention relates to a supramolecular structure comprising a plurality of fused fibrils wherein each fibril comprises a plurality of cell adhesion motif lipopeptides. The invention also relates to an aqueous medium comprising said structure, a surface for cell maintenance, cell culture and/or cell bioprocessing wherein immobilised in or on the surface is said structure, as well as uses of said structure in cell maintenance, cell culture and/or bioprocessing.

Abstract: The present invention provides a novel means for storing and/or transporting multicellular aggregates. The multicellular aggregates comprise a plurality of adjoining cells, wherein the aggregate is entrapped or encapsulated in a reversibly cross-linked hydrogel and the entrapped or encapsulated aggregate is packaged in a sealed receptacle. Methods for preparing such aggregates for storage and/or transportation from a first location to a second location are also provided, together with related methods for transporting or storing said aggregates and methods for fulfilling an order or request for said aggregates.

Abstract: The present invention relates to hydrogels which may be used to encapsulate or entrap live cells. The invention further relates to methods for transporting live cells which are encapsulated or entrapped within hydrogels from a first location to a second location. The invention further relates to method of treating a wound, disease or tissue injury, e.g. an ocular injury or a damaged ocular surface in a subject using a hydrogel comprising corneal stem cells. The hydrogels used in such methods may be ones which have been transported from a first location to a second location.

Abstract: The present invention relates to hydrogels which may be used to encapsulate or entrap live cells. The invention further relates to methods for transporting live cells which are encapsulated or entrapped within hydrogels from a first location to a second location. The invention further relates to method of treating a wound, disease or tissue injury, e.g. an ocular injury or a damaged ocular surface in a subject using a hydrogel comprising corneal stem cells. The hydrogels used in such methods may be ones which have been transported from a first location to a second location.